Research Contract: Formulation of Nanoparticles/In vivo Immunogenicity

The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to, Georgia Tech Research Corporation, Atlanta, GA 30332. This notice is not a request for competitive proposals however If interested Government shall consider all responses. This requirement is for an effective formulation of nanoparticles from recombinant proteins that maintains dual-layered antigen presentation structure and in vivo immunogenicity.

More specifically, this is a research Contract on the subject: Development of multivalent nanoparticle-based vaccines for Crimean-Congo Hemorrhagic Fever, a platform for bunyaviruses and beyond. The anticipated Period of Performance: 8/1/24-7/31/25 The NAICS code for this action is 611310. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM).

No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a Unique Entity Identification Number (UEI). A Sam.gov number may be acquired free of charge by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220